Clinical trials: Dexmedetomidine Neuroprotective Effect in Traumatic Brain Injury
Dexmedetomidine Neuroprotective Effect in Traumatic Brain Injury
Neuroprotective Effect of Dexomitomidine
patient wih mild to moderate traumatic brain injury in ICU will be randomisly distributed into two groups Group I (control group): Patients of this group receive placebo infusion for 72 hours.
- Trial name
- NCT05487742
- Testing
- Dexmedetomidine
- Where
- Egypt
- Volunteers
- 80 people
- Sponsor
- Tanta University
Traumatic Brain Injury
Comparison Between Effect of Vitamin D Versus Dexmedetomidine in Patients with Head Trauma Using Interleukin 6
in this study the investigators compare between the neuroprotective effect of vitamin d versus dexmedetomidine in patients with traumatic brain injury using interleukin 6 as inflammatory biomarker
- Trial name
- NCT06565338
- Testing
- Dexmedetomidine, Vitamin D3
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Minia University